ABSTRACT
INTRODUCTION:
In the era of 4G network and digitalization , every one wants delivery in the shortest possible time without compromising the maternal and fetous safety is beneficial for both obstetritian and the laboring woman. Labor is a multifactorial process involving good myometrial contractions, cervical ripening, dilatation and expulsion of the fetus and the placenta in an orderly manner. Various drugs are available to curtail the duration of labor e.g.: hyoscine -N-butylbromide, drotaverine and valethamate bromide. There has been an upsurge in use of these cervical dilators to avoid the complications of prolonged labor. along with early amniotomy and early administration of oxytocin, to accelerate labor many advise the use of antispasmodic agents like drotaverine, hyoscine butylbromide, dicyclomine valethamide bromide, etc. to hasten the first stage of labor. (18 This was a prospective study conducted in a tertiary center over a span of 6 months. 90 patients were randomly allotted in 3 groups.
Criteria for exclusion from study 1. Non cephalic presentation 2. Multiple pregnancy 3. Known hypersensitivity to Drotaverine or Valethamate bromide 4. Trial of labor The patients fulfilling the above criteria were included in the study. An informed written consent was obtained from all the mothers and were divided into 2 groups. Group D (Drotaverine group): Patients in this group were given injection Drotaverine 40 mg (2ml) intramuscularly at 3 cm dilatation of cervix. Dose was repeated at an interval of 2 hours till full dilatation of cervix. Maximum of 3 doses were given. Group V (Velathamate group): Patient in this group were given injection Velathamate 8 mg intramuscular at 3 cm dilatation of cervix. Dose was repeated at an interval of 1 hour till full dilatation of cervix. Maximum of 3 doses were given. Group C (Control group): This group included 30 patients and no drug was given. Details of the mothers were recorded on a prestructured proforma which include detail history of present pregnancy, menstrual history, obstetric history and any significant past history were recorded. Complete general and systemic examination was done and findings were recorded. Obstetrical examination including fundal grip, lateral grip, first and second pelvic grip were done to ascertain the number of fetus, lie and presentation. Time of injection: Injection drotaverine and velathamate was given to the mothers belonging to respected group after initial assessment. Progress of labor was assessed by per abdominal examination and per vaginal examination. The progress of labour was assessed by cervical tdilatation, duration of first stage, duration of second and third stage and maternal side effects of drugs and complications if any noted. The data of the study was tabulated and statistical analysis was done and both drugs were compared for their efficacy, side effects along with control group. RESULTS 3.6+0.5 3.6+0.5 3.6+0.4 It was observed that 97% patient were of age group between 19 to 30 years and 2% were in between 31 to 35 years in the whole study group. They are distributed in the three groups in the manner that average age in each group remains same and that factor would be statistically insignificant.
In all the three groups primi and multi gravida were devided equally. Gestational age wise distribution shows that maximum 92 % patient were 37 to 40 weeks in all groups. And 8 % patients had 41 to 42 weeks gestation period. 
